Cargando…

Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance

Ischemic stroke is caused by a thromboembolic occlusion of cerebral arteries. Treatment is focused on fast and efficient removal of the occluding thrombus, either via intravenous thrombolysis or via endovascular thrombectomy. Recanalization, however, is not always successful and factors contributing...

Descripción completa

Detalles Bibliográficos
Autores principales: Staessens, Senna, Denorme, Frederik, Francois, Olivier, Desender, Linda, Dewaele, Tom, Vanacker, Peter, Deckmyn, Hans, Vanhoorelbeke, Karen, Andersson, Tommy, De Meyer, Simon F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012484/
https://www.ncbi.nlm.nih.gov/pubmed/31048352
http://dx.doi.org/10.3324/haematol.2019.219881
_version_ 1783496241670258688
author Staessens, Senna
Denorme, Frederik
Francois, Olivier
Desender, Linda
Dewaele, Tom
Vanacker, Peter
Deckmyn, Hans
Vanhoorelbeke, Karen
Andersson, Tommy
De Meyer, Simon F.
author_facet Staessens, Senna
Denorme, Frederik
Francois, Olivier
Desender, Linda
Dewaele, Tom
Vanacker, Peter
Deckmyn, Hans
Vanhoorelbeke, Karen
Andersson, Tommy
De Meyer, Simon F.
author_sort Staessens, Senna
collection PubMed
description Ischemic stroke is caused by a thromboembolic occlusion of cerebral arteries. Treatment is focused on fast and efficient removal of the occluding thrombus, either via intravenous thrombolysis or via endovascular thrombectomy. Recanalization, however, is not always successful and factors contributing to failure are not completely understood. Although the occluding thrombus is the primary target of acute treatment, little is known about its internal organization and composition. The aim of this study, therefore, was to better understand the internal organization of ischemic stroke thrombi on a molecular and cellular level. A total of 188 thrombi were collected from endovascularly treated ischemic stroke patients and analyzed histologically for fibrin, red blood cells (RBC), von Willebrand factor (vWF), platelets, leukocytes and DNA, using bright field and fluorescence microscopy. Our results show that stroke thrombi are composed of two main types of areas: RBC-rich areas and platelet-rich areas. RBC-rich areas have limited complexity as they consist of RBC that are entangled in a meshwork of thin fibrin. In contrast, platelet-rich areas are characterized by dense fibrin structures aligned with vWF and abundant amounts of leukocytes and DNA that accumulate around and in these platelet-rich areas. These findings are important to better understand why platelet-rich thrombi are resistant to thrombolysis and difficult to retrieve via thrombectomy, and can guide further improvements of acute ischemic stroke therapy.
format Online
Article
Text
id pubmed-7012484
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ferrata Storti Foundation
record_format MEDLINE/PubMed
spelling pubmed-70124842020-02-20 Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance Staessens, Senna Denorme, Frederik Francois, Olivier Desender, Linda Dewaele, Tom Vanacker, Peter Deckmyn, Hans Vanhoorelbeke, Karen Andersson, Tommy De Meyer, Simon F. Haematologica Article Ischemic stroke is caused by a thromboembolic occlusion of cerebral arteries. Treatment is focused on fast and efficient removal of the occluding thrombus, either via intravenous thrombolysis or via endovascular thrombectomy. Recanalization, however, is not always successful and factors contributing to failure are not completely understood. Although the occluding thrombus is the primary target of acute treatment, little is known about its internal organization and composition. The aim of this study, therefore, was to better understand the internal organization of ischemic stroke thrombi on a molecular and cellular level. A total of 188 thrombi were collected from endovascularly treated ischemic stroke patients and analyzed histologically for fibrin, red blood cells (RBC), von Willebrand factor (vWF), platelets, leukocytes and DNA, using bright field and fluorescence microscopy. Our results show that stroke thrombi are composed of two main types of areas: RBC-rich areas and platelet-rich areas. RBC-rich areas have limited complexity as they consist of RBC that are entangled in a meshwork of thin fibrin. In contrast, platelet-rich areas are characterized by dense fibrin structures aligned with vWF and abundant amounts of leukocytes and DNA that accumulate around and in these platelet-rich areas. These findings are important to better understand why platelet-rich thrombi are resistant to thrombolysis and difficult to retrieve via thrombectomy, and can guide further improvements of acute ischemic stroke therapy. Ferrata Storti Foundation 2020-02 /pmc/articles/PMC7012484/ /pubmed/31048352 http://dx.doi.org/10.3324/haematol.2019.219881 Text en Copyright© 2020 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.
spellingShingle Article
Staessens, Senna
Denorme, Frederik
Francois, Olivier
Desender, Linda
Dewaele, Tom
Vanacker, Peter
Deckmyn, Hans
Vanhoorelbeke, Karen
Andersson, Tommy
De Meyer, Simon F.
Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance
title Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance
title_full Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance
title_fullStr Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance
title_full_unstemmed Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance
title_short Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance
title_sort structural analysis of ischemic stroke thrombi: histological indications for therapy resistance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012484/
https://www.ncbi.nlm.nih.gov/pubmed/31048352
http://dx.doi.org/10.3324/haematol.2019.219881
work_keys_str_mv AT staessenssenna structuralanalysisofischemicstrokethrombihistologicalindicationsfortherapyresistance
AT denormefrederik structuralanalysisofischemicstrokethrombihistologicalindicationsfortherapyresistance
AT francoisolivier structuralanalysisofischemicstrokethrombihistologicalindicationsfortherapyresistance
AT desenderlinda structuralanalysisofischemicstrokethrombihistologicalindicationsfortherapyresistance
AT dewaeletom structuralanalysisofischemicstrokethrombihistologicalindicationsfortherapyresistance
AT vanackerpeter structuralanalysisofischemicstrokethrombihistologicalindicationsfortherapyresistance
AT deckmynhans structuralanalysisofischemicstrokethrombihistologicalindicationsfortherapyresistance
AT vanhoorelbekekaren structuralanalysisofischemicstrokethrombihistologicalindicationsfortherapyresistance
AT anderssontommy structuralanalysisofischemicstrokethrombihistologicalindicationsfortherapyresistance
AT demeyersimonf structuralanalysisofischemicstrokethrombihistologicalindicationsfortherapyresistance